Population
Families and patients with malignant hyperthermia susceptibility
Design
Review
Authors
Loading...
Restricts presymptomatic DNA testing for malignant hyperthermia to linked families; leaves open broader gene discovery.
Genetic heterogeneity limits presymptomatic DNA testing for malignant hyperthermia to families with proven linkage to chromosome 19q13.1-13.2.
Ball et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: